Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Pemigatinib is used in adults to treat bile duct cancer that has spread to other parts of the body (metastatic) or cannot be removed with surgery.Is Pemigatinib good for cholangioc···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：208
Pemigatinib is an effective treatment for advanced or metastatic cholangiocarcinoma caused by FGFR2 fusion or rearrangement.Is the treatment effect of Pemigatinib goodIn the FIGHT-···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：188
Pemigatinib leads to constitutive activation of FGFR by activating FGFR amplification and fusion, thereby inhibiting FGFR1-3 phosphorylation and signaling and decreasing cell viabi···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：195
Venetoclax is a targeted anti-cancer drug used to treat certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Venetoclax work···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：227
Venetoclax is a novel oral small molecule drug that targets the BCL-2 protein to kill cancer cells by inducing the endogenous apoptotic pathway of tumor cells. In addition to AML, ···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：314
Venetoclax is a small molecule drug that targets BCL-2 and is able to promote normal apoptosis of cancer cells by blocking the BCL-2 protein. Overexpression of BCL-2 protein in can···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：218
Venetoclax is an oral anticancer drug targeting BCL-2 that promotes apoptosis of tumor cells by inhibiting the activity of BCL-2 protein. In China, venetoclax has been approved for···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：179
By binding to BCL-2 protein, venetoclax inhibits the obstruction of apoptosis of tumor cells and effectively kills cancer cells. Venetoclax was approved by the NMPA in 2020 for the···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：219
Venetoclax is a small molecule drug approved in combination with azacitidine for the treatment of acute myeloid leukemia. Initially indicated as chronic lymphocytic leukemia, it ha···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：207
Venetoclax is an oral targeted drug that can effectively inhibit the anti-apoptotic function of BCL-2 protein and restore the normal death of cancer cells. The drug is usually used···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：274
Venetoclax is a targeted drug used in the treatment of a variety of hematologic malignancies, mainly by blocking the activity of BCL-2 protein to promote apoptosis of tumor cells. ···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：231
Venetoclax is the only approved selective inhibitor of Bcl-2 in the world. By binding Bcl-2 protein with high affinity, Bax/Bak-dependent apoptosis is induced and platelet damage i···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：219
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3172024-09-07
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：102025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：232025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：242025-27-11
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended：3062025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended：2692025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended：3492024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended：2492024-24-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
